[Congressional Record (Bound Edition), Volume 161 (2015), Part 12]
[Senate]
[Page 16523]
[From the U.S. Government Publishing Office, www.gpo.gov]




    IMPROVING REGULATORY TRANSPARENCY FOR NEW MEDICAL THERAPIES ACT

  Mr. PORTMAN. Madam President, I ask unanimous consent that the 
Committee on Health, Education, Labor, and Pensions be discharged from 
further consideration of H.R. 639 and the Senate proceed to its 
immediate consideration.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The clerk will report the bill by title.
  The senior assistant legislative clerk read as follows:

       A bill (H.R. 639) to amend the Controlled Substances Act 
     with respect to drug scheduling recommendations by the 
     Secretary of Health and Human Services, and with respect to 
     registration of manufacturers and distributors seeking to 
     conduct clinical testing.

  There being no objection, the Senate proceeded to consider the bill.
  Mr. PORTMAN. I ask unanimous consent that the substitute amendment, 
which is at the desk, be considered and agreed to, the bill, as 
amended, be read a third time and passed, and the motion to reconsider 
be considered made and laid upon the table.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The amendment (No. 2748) in the nature of a substitute was agreed to.
  (The amendment is printed in today's Record under ``Text of 
Amendments.'')
  The amendment was ordered to be engrossed, and the bill to be read a 
third time.
  The bill was read the third time.
  The bill (H.R. 639), as amended, was passed.

                          ____________________